HHS Logo U.S. Department of Health & Human Services Divider arrowNIH logo National Institutes of Health Alt desc
Skip Over Navigation Links
scientists sitting at a table

New Funding Opportunity to Repurpose Existing Drugs or Biologics

NCATS released a funding opportunity to explore a potential new use of an existing drug or biologic through its Bench-to-Clinic Repurposing initiative.


Work with Us

Learn more about how you can access funding and collaborate with the New Therapeutic Uses program.

Contact Christine Colvis, Ph.D.

Discovering New Therapeutic Uses for Existing Molecules

Through its Discovering New Therapeutic Uses for Existing Molecules (New Therapeutic Uses) program, NCATS aims to improve the process of developing new treatments and cures for disease by finding new uses for existing therapies that already have cleared several key steps along the development path. This also is known as drug repurposing. Learn more about New Therapeutic Uses.

Find NCATS Programs & InitiativesAccess NCATS Expertise & Resources

    New Therapeutic Uses and Drug Repurposing

    Therapeutic development is a costly, complex and time-consuming process. A novel drug can take 10 to 15 years and more than $2 billion to develop, and failure rates occur in about 95 percent of human studies. The high therapeutic development failure rate means there are many existing, partially developed therapeutic candidates that could be repurposed for use in new disease indications. Bringing together the best assets from pharmaceutical companies with the best new ideas from academic researchers could produce new treatments much more quickly than starting from scratch. Learn more about the purpose of the New Therapeutic Uses program.